Pharmacologic Management for Ventricular Arrhythmias: Overview of Anti-Arrhythmic Drugs.

J Clin Med · 2022 · PMC9181251 · PMID 35683620

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Digoxin use has been largely relegated to advanced heart failure and refractory atrial fibrillation, as initial trials showed a trend toward increased mortality in these populations [ 137 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.